RNS Number : 0241Q
GlaxoSmithKline PLC
23 February 2021
GlaxoSmithKline plc
(the '
Company
')
Transaction notification
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
Ms D Conrad
|
|
b)
|
Position/status
|
SVP, Human Resources
|
|
c)
|
Initial notification/
amendment
|
Initial notification
|
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
|
a)
|
Description of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|
b)
|
Nature of the transaction
|
Purchase of ADSs
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
$34.5350
|
3,400
|
|
|
|
|
|
|
|
d)
|
Aggregated information
|
N/A (single transaction)
|
|
Aggregated volume Price
|
|
|
e)
|
Date of the transaction
|
2021-02-19
|
|
f)
|
Place of the transaction
|
New York Stock Exchange (XNYS)
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected]com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
DSHKXLBLFLLBBBL